Literature DB >> 12406888

Heterotypic interactions between transferrin receptor and transferrin receptor 2.

Todd M Vogt1, Aaron D Blackwell, Anthony M Giannetti, Pamela J Bjorkman, Caroline A Enns.   

Abstract

Cellular iron uptake in most tissues occurs via endocytosis of diferric transferrin (Tf) bound to the transferrin receptor (TfR). Recently, a second transferrin receptor, transferrin receptor 2 (TfR2), has been identified and shown to play a critical role in iron metabolism. TfR2 is capable of Tf-mediated iron uptake and mutations in this gene result in a rare form of hereditary hemochromatosis unrelated to the hereditary hemochromatosis protein, HFE. Unlike TfR, TfR2 expression is not controlled by cellular iron concentrations and little information is currently available regarding the role of TfR2 in cellular iron homeostasis. To investigate the relationship between TfR and TfR2, we performed a series of in vivo and in vitro experiments using antibodies generated to each receptor. Western blots demonstrate that TfR2 protein is expressed strongest in erythroid/myeloid cell lines. Metabolic labeling studies indicate that TfR2 protein levels are approximately 20-fold lower than TfR in these cells. TfR and TfR2 have similar cellular localizations in K562 cells and coimmunoprecipitate to only a very limited extent. Western analysis of the receptors under nonreducing conditions reveals that they can form heterodimers.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12406888     DOI: 10.1182/blood-2002-09-2742

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  11 in total

Review 1.  Crossing the Iron Gate: Why and How Transferrin Receptors Mediate Viral Entry.

Authors:  Marianne Wessling-Resnick
Journal:  Annu Rev Nutr       Date:  2018-05-31       Impact factor: 11.848

2.  CD81 promotes both the degradation of transferrin receptor 2 (TfR2) and the Tfr2-mediated maintenance of hepcidin expression.

Authors:  Juxing Chen; Caroline A Enns
Journal:  J Biol Chem       Date:  2015-01-29       Impact factor: 5.157

3.  Transferrin receptor 2: evidence for ligand-induced stabilization and redirection to a recycling pathway.

Authors:  Martha B Johnson; Juxing Chen; Nicholas Murchison; Frank A Green; Caroline A Enns
Journal:  Mol Biol Cell       Date:  2006-12-20       Impact factor: 4.138

4.  Extrahepatic deficiency of transferrin receptor 2 is associated with increased erythropoiesis independent of iron overload.

Authors:  Aaron M Wortham; Devorah C Goldman; Juxing Chen; William H Fleming; An-Sheng Zhang; Caroline A Enns
Journal:  J Biol Chem       Date:  2020-02-13       Impact factor: 5.157

5.  Hepcidin and ferroportin expression in breast cancer tissue and serum and their relationship with anemia.

Authors:  X Pan; Y Lu; X Cheng; J Wang
Journal:  Curr Oncol       Date:  2016-02-18       Impact factor: 3.677

6.  Transferrin receptor 2 protein is not expressed in normal erythroid cells.

Authors:  Alessia Calzolari; Silvia Deaglio; Nadia Maria Sposi; Eleonora Petrucci; Ornella Morsilli; Marco Gabbianelli; Fabio Malavasi; Cesare Peschle; Ugo Testa
Journal:  Biochem J       Date:  2004-08-01       Impact factor: 3.857

7.  Stoichiometries of transferrin receptors 1 and 2 in human liver.

Authors:  Maja Chloupková; An-Sheng Zhang; Caroline A Enns
Journal:  Blood Cells Mol Dis       Date:  2009-10-12       Impact factor: 3.039

8.  Transferrin-directed internalization and cycling of transferrin receptor 2.

Authors:  Juxing Chen; Jinzhi Wang; Kathrin R Meyers; Caroline A Enns
Journal:  Traffic       Date:  2009-07-06       Impact factor: 6.215

9.  The transferrin receptor modulates Hfe-dependent regulation of hepcidin expression.

Authors:  Paul J Schmidt; Paul T Toran; Anthony M Giannetti; Pamela J Bjorkman; Nancy C Andrews
Journal:  Cell Metab       Date:  2008-03       Impact factor: 27.287

10.  Interaction of the hereditary hemochromatosis protein HFE with transferrin receptor 2 is required for transferrin-induced hepcidin expression.

Authors:  Junwei Gao; Juxing Chen; Maxwell Kramer; Hidekazu Tsukamoto; An-Sheng Zhang; Caroline A Enns
Journal:  Cell Metab       Date:  2009-03       Impact factor: 27.287

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.